Ethical and statistical power issues limit the use of randomized controlled trials to study medication and vaccine use during ...

Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...

The new tool, available as a phone app, helps identify comorbidities and produces a score to guide clinicians.

The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...

A new way to treat asthma symptoms and even repair previously irreversible lung damage could be on the horizon following the discovery of a potential new therapeutic target by scientists at the ...

For decades, scientists have thought they understood the biochemical machinery that causes asthma-inflammation in the lungs that constricts airways and makes it hard to breathe.

We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to inflammatory responses, can be caused throughout our lifetime by a variety of ...

DENVER — A brief universal screening for asthma, even in a community with an already high prevalence of asthma, can further improve identification of children with undiagnosed asthma, according to a ...